Faculty Opinions recommendation of A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 11
(3)
◽
pp. 254-258
◽
Keyword(s):
2011 ◽
Vol 47
(8)
◽
pp. 1138-1145
◽
2009 ◽
Vol 11
(3)
◽
pp. 264-269
◽
2017 ◽
Vol 117
(10)
◽
pp. 1478-1485
◽